
    
      Participants will be randomized at a 2: 1 ratio to receive new pharmaceutical form Minoxidil
      5% and placebo, respectively. Through this method, it is possible to obtain more information
      about the effectiveness of investigational product.

      The primary objective of the study is to evaluate efficacy by assessing nonvellus target area
      hair count after using a new topical formulation of Minoxidil 5% compared to placebo applied
      topically for 24 weeks.

      Among the secondary objectives, other aspects of effectiveness and safety will be evaluated,
      such as quality of life, vital signs, and other parameters.
    
  